Niloufar Sadat Nourbakhsh
Overview
Explore the profile of Niloufar Sadat Nourbakhsh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
61
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nourbakhsh N, Naeimi S, Moghanibashi M, Baradaran B
Tissue Cell
. 2024 Aug;
91:102530.
PMID: 39191051
Prostate cancer poses a significant global health challenge, ranking as the second most prevalent and fifth most lethal malignancy among males. The intricate interplay between androgen signaling and the immune...
2.
Ghorbaninezhad F, Leone P, Alemohammad H, Najafzadeh B, Nourbakhsh N, Prete M, et al.
Int J Mol Med
. 2022 Feb;
49(4).
PMID: 35137914
Tumor necrosis factor‑α (TNF‑α) is a pleiotropic pro‑inflammatory cytokine that contributes to the pathophysiology of several autoimmune diseases, such as multiple sclerosis, inflammatory bowel disease, rheumatoid arthritis, psoriatic arthritis and...
3.
Nomiri S, Karami H, Baradaran B, Javadrashid D, Derakhshani A, Nourbakhsh N, et al.
Biomed Pharmacother
. 2021 Dec;
146:112537.
PMID: 34922114
Background: Ovarian cancer (OC) is one of the worrisome gynecological cancers worldwide. Given its considerable mortality rate, it is necessary to investigate its oncogenesis. Methods: In this study, we used...
4.
Derakhshani A, Rostami Z, Safarpour H, Shadbad M, Nourbakhsh N, Argentiero A, et al.
Molecules
. 2021 Apr;
26(8).
PMID: 33920054
Over the past decade, there have been remarkable advances in understanding the signaling pathways involved in cancer development. It is well-established that cancer is caused by the dysregulation of cellular...
5.
Javadrashid D, Baghbanzadeh A, Hemmat N, Hajiasgharzadeh K, Nourbakhsh N, Lotfi Z, et al.
Immunol Lett
. 2021 Mar;
232:48-59.
PMID: 33647329
Pancreatic ductal adenocarcinoma has a poor 5-year survival rate that makes it one of the most fatal human malignancies. Unfortunately, despite the serious improvement in the survival of most cancers,...
6.
Derakhshani A, Silvestris N, Hemmat N, Asadzadeh Z, Shadbad M, Nourbakhsh N, et al.
Molecules
. 2020 Nov;
25(21).
PMID: 33167431
Since the current treatments have not resulted in the desired outcomes for melanoma patients, there is a need to identify more effective medications. Together with other snake venom proteins, cytotoxin-II...